Correlation Between Summit Therapeutics and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Summit Therapeutics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Tarsus Pharmaceuticals.
Diversification Opportunities for Summit Therapeutics and Tarsus Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Summit and Tarsus is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.62 times more return on investment than Tarsus Pharmaceuticals. However, Summit Therapeutics is 1.62 times more volatile than Tarsus Pharmaceuticals. It trades about 0.28 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 1,821 in Summit Therapeutics PLC on October 28, 2024 and sell it today you would earn a total of 555.00 from holding Summit Therapeutics PLC or generate 30.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Summit Therapeutics PLC vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Summit Therapeutics PLC |
| Tarsus Pharmaceuticals |
Summit Therapeutics and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Summit Therapeutics and Tarsus Pharmaceuticals
The main advantage of trading using opposite Summit Therapeutics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |